Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Charm Therapeutics Ltd.

Headquarters: London, United Kingdom
Year Founded: 2021
Status: Private

BioCentury | Oct 10, 2024
Discovery & Translation

Baker and DeepMind Nobel: Two sides of a computational protein coin

Protein design updates its engine: The field’s shift from physical models to deep learning
BioCentury | Sep 12, 2024
Management Tracks

Ovid promotes Alexander to COO

Plus: Tyra hires Warner as CMO and updates from Senisca, Closed Loop, NanoSyrinx and more
BioCentury | Jun 27, 2024
Data Byte

Prepping for a techbio future, Nvidia invests in another AI drug discovery play

Tallying the AI & GPU provider’s investments in biotechs
BioCentury | Apr 30, 2024
Management Tracks

Innovent hires Gracell vet Samuel Zhang as CBO

Plus: CEO changes at Lexicon, Avacta and Sphere Fluidics, and updates from Generate, Charm, ViaNautis and more
BioCentury | May 11, 2023
Discovery & Translation

Keeping up with the protein designers

As machine learning methods leapfrog each other, protein design companies must navigate the benefits and challenges of an ever-evolving toolbox
BioCentury | Jan 5, 2023
Management Tracks

Sanofi’s Sarchi heads to Replimune

Plus: Albers joins Atlas, new CBO at Altimmune and updates from Nuvig, Zymeworks, Fulcrum, Step, Charm, Kymera and more
BioCentury | Aug 13, 2022
Product Development

Protein design updates its engine

The field is shifting from physical models to deep learning
BioCentury | Jun 10, 2022
Finance

June 9 Quick Takes: Venture rounds for Tessa, Degron, Ancora, Charm and Relation

Plus Arnay partners with Alloy and updates from DBV and more
Items per page:
1 - 8 of 8